Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York

Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York

This case series reviews four critically ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [coronavirus disease 2019 (COVID-19)] suffering from pneumatosis intestinalis (PI) during their hospital admission. All patients received the biological agent tocilizumab...

Full description

Bibliographic Details
Main Authors: Santiago J. Miyara, Lance B. Becker, Sara Guevara, Claudia Kirsch, Christine N. Metz, Muhammad Shoaib, Elliot Grodstein, Vinay V. Nair, Nicholas Jandovitz, Alexia McCann-Molmenti, Kei Hayashida, Ryosuke Takegawa, Koichiro Shinozaki, Tsukasa Yagi, Tomoaki Aoki, Mitsuaki Nishikimi, Rishabh C. Choudhary, Young Min Cho, Stavros Zanos, Stefanos Zafeiropoulos, Hannah B. Hoffman, Stacey Watt, Claudio M. Lumermann, Judith Aronsohn, Linda Shore-Lesserson, Ernesto P. Molmenti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Medicine
Subjects:
pneumatosis intestinalis
COVID-19
SARS-CoV-2
mesenteric ischemia
ischemia-reperfusion injury
molecular targeted therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.638075/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.638075/full

Similar Items